Tirzepatide reduces muscle fat infiltration relative to insulin deglucec in people with type 2 diabetes (SURPASS-3 MRI)
Risks and side effects of GLP-1 in older adults The clearest risks for seniors are significant digestive issues, a higher chance of muscle and bone loss, and a greater likelihood of fluid and electrolyte imbalances
Mediterranean Journal of Rheumatology, 36 (1), 28-35
BMI Reduction: Participants receiving liraglutide achieved a mean BMI reduction of 4.3%, compared with a 0.3% reduction observed in the placebo group
Aetna offers several plan types in Arizona including PPO, HMO, and marketplace plans some of which may include coverage for GLP-1 obesity medications when medically indicated
The surprising thing is that it took the market a really long time to realize the GLP-1 threat